Skip to main content
Clinical Trials/NCT07662083
NCT07662083Not yet recruitingNot Applicable

Randomized Controlled Trial Evaluating Trans Auricular Vagal Nerve Stimulation in Patients With Irritable Bowel Syndrome Constipation Subtype

West Virginia University1 site in 1 country80 target enrollmentStarted: July 1, 2026Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
80
Locations
1

Study Overview

Brief Summary

This study evaluates the efficacy and safety of transcutaneous auricular vagus nerve stimulation (ta-VNS) in adults with constipation-predominant irritable bowel syndrome (IBS-C). Participants will be randomized to receive either active or sham stimulation using a non-invasive auricular device over a 60-day period.

The primary objectives are to assess changes in symptom severity and quality of life using validated instruments, including the IBS Symptom Severity Scale (IBS-SSS) and the IBS Quality of Life questionnaire (IBS-QOL). Secondary assessments include safety and participant compliance.

This study aims to determine whether ta-VNS is an effective non-invasive therapeutic modality for improving symptoms and quality of life in patients with IBS-C.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Referred to the WVU Department of Gastroenterology and Hepatology
  • Diagnosis of IBS-C

Exclusion Criteria

  • Failure of second-line therapy with secretagogues (linaclotide, lubiprostone, plecanatide, or tenapanor)
  • Failure of third-line therapy with tegaserod
  • Known debilitating psychiatric illness
  • Cognitive impairment
  • Pregnancy
  • Prisoners
  • Active substance use disorder
  • Concurrent opioid use
  • History of major gastrointestinal surgery resulting in luminal alteration
  • History of vagotomy
  • Secondary causes of constipation (e.g., opioid use, uncontrolled hypothyroidism, celiac disease)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Zain Sobani

Assistant Professor

West Virginia University

Study Sites (1)

Loading locations...

Similar Trials